Connect with us

BUSINESS

Australis Capital Inc (OTCMKTS: AUSAF): Change Of Name And East Coast Entry

Published

on

Australis Capital Inc (OTCMKTS: AUSAF), a community and culture-based cannabis company, recently announced the change of name to Audacious Brands. However, the company’s ticker symbol will remain the same on the OTC. In addition, the company also announced its plan to enter Massachusetts through partnerships with Belle Fleur Holdings LLC and Rapper Weed. 

The company has entered this Agreement through its subsidiary ALPS, which it has acquired recently to be part of the global horticulture market’s Sustainable Controlled Environment Agriculture Industry.

Change of name and expansion plan

Australis plans to consolidate its brands, focused on the U.S. adult-use market, under the new name; while intending to launch additional product lines in the coming months. The company also announced that it is in the advanced stages of discussions to venture into newer jurisdictions, including a facility and supply partnership in Massachusetts. 

Australis also reported some additional transactions close to the agreement stage, including a retail facility in an underserved market and an edibles company in California. Its merger and acquisition strategy follows strict discipline with previously announced criteria, including accretive transactions and disruption. Terry Booth, the Australis CEO, expressed that Audacious stands for breaking with tradition, being bold, confident, and doing things differently. He added that the new name for its adult-use operations reflects its corporate culture and the recent changes in its execution and operation strategies. Its motto is to ignite and excite the customer base. 

East coast business strategy

ALPS, an Australis’ majority-owned subsidiary, provides customized design solutions and a range of services that allow optimizing yield and quality while minimizing inputs and resources. The company entered a facility engineering and design services contract with Belle Fleur and an agreement for the APIS Compliance and Maintenance services. Belle Fleur and Rapper Weed are the holders of the Tier 11 license for high-tech indoor grow facility in Blandford, Massachusetts, which is the most extensive cultivation license available, allowing up to 100,000 sq ft of canopy space in the state. 

Massachusetts has legalized cannabis for medical and adult use and has approved 1 million sq ft of cultivation space. However, cultivation in the state is likely to operate at a premium, given the projected demand of more than $1 billion by 2024. The recent partnership will position Audacious to capitalize on this opportunity and become profitable as the Multiple State Operator.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

BUSINESS

Delta 9 Cannabis Inc. (OTCMKTS: DLTNF) Makes Executive Appointment, Amyris Inc. (NASDAQ: AMRS) Launches Skincare Product

Published

on

Delta 9 Cannabis Inc. (OTCMKTS: DLTNF) has announced the appointment of David Kideckel to the newly created EVP Head of Strategy, Corporate Development & Capital Markets position to spearhead the company’s next growth expansion phase. David has around 20 years of combined experience in capital markets and industry. 

Delta 9 appoints David Kideckel to head the expansion phase 

Delta 9 CEO John Arbuthnot said, “I am extremely pleased to welcome David to our team, propelling our capital markets strategy and reach, through his wealth of experience. David was one of the leading cannabis analysts and has an exceptional network of contacts with an in-depth knowledge of the cannabis industry and its subsectors. David’s appointment reflects our commitment to having best-in-class talent to advance the Company’s growth trajectory strategically and expeditiously.”

David commented, “Of all the companies I have evaluated over the last several years, Delta 9 has incredible potential and I’m proud to join a seasoned team that is on the verge of steady and continuous growth within an explosive industry.”

Amyris launches first of the Terasana Clinical skincare products 

Amyris Inc. (NASDAQ: AMRS) has launched the Terasana Clinical clean skincare brand. The launch is the first of the three brand launches the company anticipates launching this summer. The first skincare brand, Clear + Control Healthy Skin Serum, addresses irritation, skin flaking, dry skin, and redness. The proprietary formulation in the product combines Cannabigerol (CBG) and Squalane. 

CEO John Melo said, “CBG has a variety of proven skin benefits and through our well-established fermentation technology, we are able to manufacture CBG at scale and at a much lower cost than existing alternatives. We believe that clean CBG has opened up new avenues for innovation in sustainable and effective skincare and that it has the potential to be a breakthrough in addressing the acne market. We are on track to launch three new clean beauty consumer brands this month.”

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

BUSINESS

Decibel Cannabis Company Inc. (OTCMKTS: DBCCF) And Affinor Growers Inc (OTCMKTS: RSSFF) Announce Stock Options Grant

Published

on

Decibel Cannabis Company Inc. (OTCMKTS: DBCCF) has announced the $ 2.5 million stock options grant to its CEO as per its stock option plan effective August 17, 2021. 

Decibel Cannabis grant CEO stock options 

The options granted are exercisable for one common share in the company’s capital at $0.34 per share, which it’s the shares’ closing price on the TSX Venture Exchange on August 17, 2021. Notably, the Options will vest on January 1 each year through 2024 in equal installments, and they have an expiry of five years.

Decibel is rigorous in its approach to the process and craftsmanship required to produce the highest-quality cannabis products and retail experiences. Along with its wholly-owned retail business, Prairie Records, Decibel operates three production houses. The Qwest Estate, located in Creston, British Columbia, is known for the Qwest Reserve and Qwest brand. Thunderchild Cultivation, located in Battleford, Saskatchewan, and the Plant extraction facility in Calgary. 

Affinor appoint Bruce Kahkesh to the board 

Affinor Growers Inc (OTCMKTS: RSSFF) has announced the appointment of Bruce Kahkesh to its board to help with business execution and a five-year domestic and international growth plan. Bruce is the CEO and founder of the National Capital corp and also National Capital Management Corp CEO. He offers enterprise leadership to the development and execution of strategies creating value for shareholders and clients. He pursues investment alternatives to create consistent returns for shareholders. 

Nick Brusatore, Affinor CEO, said, “Bruce is a financial leader with a strong ability to assist businesses with the larger game plan. Affinor’s 5-year growth plan for Canada (available on our website) includes revenue from food products, cannabis and licensed, turnkey build-outs. Bruce’s experience in structuring financial leverage provides essential advisory board expertise.”

Also, the company has announced the grant of 1 million stock options to a consultant of Affinor to acquire 1 million common shares of the company’s capital. 

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

BUSINESS

Cannabix Technologies Inc. (OTCMKTS: BLOZF) Granted FAIMS Patent, 22nd Century Group Inc. (NASDAQ: XXII) Make Board Appointment

Published

on

Cannabix Technologies Inc. (OTCMKTS: BLOZF) has announced receipt of patent No 17/019728 titled “Apparatus and Methods for Detection of Molecules,” from the US Patent and Trademark Office.

Cannabix’s FAIMS receives a patent. 

The company’s field asymmetric waveform ion mobility spectrometry (FAIMS) -based cannabis breathalyzer technology is the subject of this patent. The patent is the result of extensive research and development efforts in non-volatile molecular sampling, ion mobility spectrometry, and fluid dynamics. These advancements are useful in a variety of domains involving the detection of target molecules in breath.

Cannabix is working on FAIMS-based drug screening equipment to identify cannabis in exhaled air for laboratories, law enforcement, and other end users. The company is leveraging the FAIMS technology to detect non-volatile chemical 9-tetrahydrocannabinol (“THC”) in a breath. Ion mobility filtering techniques related to mass spectrometry are used in the Cannabix FAIMS cannabis breathalyzer gadget. The Cannabix device comprises several modules that work together to allow sample intake, filtering, detection, and ionization at atmospheric pressure. Additionally, the gadget can connect to a mass spectrometer directly for confirmation using gold standard methods.

22nd Century Group appoint Anthony Johnson to board 

22nd Century Group Inc. (NASDAQ: XXII) has announced Anthony Johnson’s appointment to the Board of Directors. Johnson is a leading biotech and life sciences executive leader with vast expertise in tech development, corporate strategy, business development, and marketing. He will serve on the Scientific Advisory and Compensation Committees. 

Nora Sullivan, 22nd Century’s Board chair, said, “Anthony is an industry visionary in the biotechnology field and a strategy expert in both domestic and international capacities. He also holds extensive experience with boards and committees, in mentoring businesses and entrepreneurs, and in serving communities. We are fortunate to welcome him to our board of directors where we are confident his contributions will have a significant impact on our Company’s business development, commercialization, and value creation efforts.”

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

Trending Stories